WP IP

News and commentary on IP issues

Practical Tips for Patenting Antibodies in Europe

Antibody
The patenting of proteins is well established in Europe as long as they meet the requirements of novelty and inventive step.Antibodies are a specific type of protein, and to obtain useful patent protection for these, there are specific requirements to take into consideration.We have previously written about the European Patent Office's Guidelines f...
Continue reading
  3849 Hits
3849 Hits

Developing Drugs for Developing World Diseases: The Role of Patents

Mosquito
The Covid-19 pandemic has brought the issue of patents for medicines (in particular vaccines in the case of Covid) to the fore.From the debate surrounding enhancing distribution of Covid vaccines in the developing world by implementing a patent waiver, it is clear that the oft-heard argument that intellectual property to protect such vital products...
Continue reading
  3457 Hits
3457 Hits

The Unified Patent Court and Unitary Patent are coming

UPC
The long-awaited Unified Patent Court opens its doors on 1 June 2023 now that Germany has ratified the UPC Agreement. Alongside this, patents granted at the European Patent Office will be able to be registered for a single Unitary right covering certain EU member states (in addition to other states being individually registered separately in the co...
Continue reading
  3322 Hits
3322 Hits

DABUS at the UK's Supreme Court - inventorship of AI created inventions to be decided

Supreme Court of United Kingdom
On 2 March 2023, Robert Jehan and Dr Ryan Abbott will appear before the Supreme Court of the United Kingdom to argue that the Patents Act 1977 can permit the granting of patents for the DABUS patent applications. The appellant, Dr Thaler, created an Artificial Intelligence (AI) machine known as DABUS that in turn, in the absence of a traditional hu...
Continue reading
  4561 Hits
4561 Hits

EPO Board of Appeal Decision J0008/20 on AI Inventor DABUS - Commentary by Robert Jehan

web-gc67d340f3_1920
On 6 July 2022 the European Patent Office's Legal Board of Appeal published its reasoned decision J0008/20 explaining why it refused Dr Thaler's appeal at the end of the oral proceedings held on 21 December 2021. The decision establishes very important principles in law in relation to the patentability of inventions created by AI systems, that...
Continue reading
  7285 Hits
7285 Hits

Williams Powell wins MIP award of European Cross-Border Patent Litigation Team

Managing-IP-Award
We are delighted to announce that Williams Powell was presented with the special award of European Cross-Border Patent Litigation Team of the Year for the Stephen Thaler v Comptroller General of Patents, Designs and Trade Marks (DABUS) case at the prestigious Managing IP Awards on 15 June 2022. Williams Powell was recognised for the work of Robert ...
Continue reading
  4197 Hits
4197 Hits

Sequence Listings Looking Towards the "Big Bang"

BigBang
The beginning of July sees a shake up in how sequence listings are to be presented in patent applications around the world. After almost 25 years, WIPO has updated its standard from ST.25 to ST.26, and relevant patent applications at the International Bureau and in all WIPO contracting states (including both the EPO and the UK IPO) will need to inc...
Continue reading
  3475 Hits
3475 Hits

UK Patent Attorneys able to represent clients before the European Unified Patent Court

Representation
It has been confirmed that European patent attorneys having a relevant UK qualification will be able to represent clients directly before the Unified Patent Court. All of Williams Powell's patent attorneys have the relevant qualifications and will therefore be entered on the list of representatives. As previously reported, the new UPC system i...
Continue reading
  3751 Hits
3751 Hits

Williams Powell ranked top 100 member firm of Azami Global

Azami2
Wiliams Powell is proud to have been selected as one of Azami Global's Top 100 Member Firms for 2021. The Top 100 Member Firms are nominated by their peers based on the values of Quality, Integrity, Transparency, Professionalism, and Community. Azami Global is the single largest network provider of services, offering members expanded global reach a...
Continue reading
  3246 Hits
3246 Hits

European Unitary Patent in 2022?

Europe
As the European Patent Office announces transitional provisions ready for entry into force of the UPC Agreement, it is starting to look like we may have the first European Unitary Patent within the next year or so. While there will of course be competition to see who manages to get the first Unitary Patent, there are also serious strategi...
Continue reading
  4150 Hits
4150 Hits

Plausibility - EPO stays proceedings in view of Enlarged Board Referral

moth-g635cf3fe4_1920
The European Patent Office has announced a stay of all examination/opposition proceedings involving applications/patents in which the assessment of inventive step is exclusively based on evidence that was not publicly available before the filing date, and in which the decision depends entirely on the outcome of Referral G2/21 (Plausibility), u...
Continue reading
  4976 Hits
4976 Hits

A Unified Patent Court for Europe - Coming Soon?

UPC
Europe may soon have its Unified Patent Court and Williams Powell is ready to assist you. With attorneys qualified for the European Patent Litigation Certificate (which gives UPC rights of representation) and as a Patent Attorney Advocate & Litigator (which gives rights of representation in the UK Courts) we are well-placed not only to obtain I...
Continue reading
  4359 Hits
4359 Hits

Patent Sufficiency reconsidered by UK Court of Appeal

Sufficiency
This Court of Appeal Decision concerned two families of patents held by FibroGen:Family A and Family B relating to H1F-PH inhibitors for the treatment of (respectively) CKD anaemia (anaemia associated with chronic kidney disease) and ACD (anaemia of chronic disease).Family A was published before the relevant priority date of Family B, and so i...
Continue reading
  3679 Hits
3679 Hits

UK Court of Appeal judgment on the DABUS AI as inventor appeal

brain-4863428_640
On 21 September 2021 the Court of Appeal handed down its judgment in THALER v COMPTROLLER GENERAL OF PATENTS TRADE MARKS AND DESIGNS [2021] EWCA Civ 1374. The Court of Appeal, in a split 2/1 decision dismissed Dr Thaler's appeal. Lord Justice Arnold held in his judgment that there is no rule of law that a new intangible produced by existing ta...
Continue reading
  4932 Hits
4932 Hits

DABUS the AI system confirmed as the inventor and Dr Stephen Thaler as the owner of the DABUS inventions

web-3706562_1920
Today a second country has confirmed that DABUS, an artificial intelligence system, can be named as the inventor in a patent and that Dr Stephen Thaler as the rightful owner of the DABUS inventions. Following from patent applications filed by Williams Powell, first in the United Kingdom and at the European Patent Office, then by way of an inte...
Continue reading
  5426 Hits
5426 Hits

Illumina – Shining a light on DNA Sequencing Technology

Sequence
In this English High Court case relating to the infringement and validity of five patents held by Illumina, Mr Justice Birss decided upon several hot topics in the biotech patenting world. We summarise some of the most interesting points here. The Technology Briefly, the patents related to DNA sequencing technology.More specifically, three of ...
Continue reading
  4667 Hits
4667 Hits

Claiming Antibodies in European Patent Applications

Immune
In the past year, we have all heard more about antibodies in the general news than anyone ever desired. When we are exposed to pathogens, antibodies form a vital part of our immune systems in protecting us from deadly diseases.Isolated from the body or synthetically produced, antibodies can have many uses and are particularly important as therapeut...
Continue reading
  5412 Hits
5412 Hits

Defining Amino Acid and Nucleic Acid Sequences in European Patent Applications

BioSeq
Welcome guidance on the interpretation of claims to amino acids and nucleic acids defined by their sequences is provided by updated Guidelines for Examination at the European Patent Office now in force. New section F-IV-4.24 sets out that both amino acid sequences and nucleic acid sequences can be defined by "percentage identity". The percenta...
Continue reading
  5064 Hits
5064 Hits

UK IP rights - address for service changes

As of 1 January 2021, a UK, Gibraltar or Channel Islands address for service will be required for any new UK IP rights. This change has received parliamentary approval and is implemented in a UK IPO notice (TPN 2/2020) dated 21 December 2020. Action should be taken and we would be very happy to assist.  If your IP rights are&nbs...
Continue reading
  5320 Hits
5320 Hits

Breaking News - DABUS granted Right to Appeal UK Judgement

We are delighted that the UK Court of Appeal has today granted Dr Thaler the right to appeal the DABUS decision, which involves the important issue of patentability of inventions created by AI systems. Williams Powell is handling the DABUS patent applications as well as the UK and EPO appeals. The cases had been rejected by the UK High Court. The o...
Continue reading
  4413 Hits
4413 Hits

By accepting you will be accessing a service provided by a third-party external to https://www.williamspowell.com/